Myocardial infarction remains one of the leading causes of death worldwide. Following an infarction, part of the heart muscle ...

Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is ...

Secretome raises $30M Series A to advance STM-01 into Phase 2 and 3 late-stage trials for Duchenne cardiomyopathy treatment.

A research team co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson's Sarver Heart Center found that a subset of artificial heart patients can regenerate heart ...

The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure. Researchers in the Michael E. DeBakey Department of Surgery at ...

TTUHSC’s Mahmoud Salama Ahmed, Ph.D., and an international team of researchers investigated novel therapeutics and existing FDA-approved therapeutic regimens for cardiac regeneration. Their study was ...

For millions of people, losing muscle isn't just about weakness; it's about losing independence. Whether caused by Duchenne muscular dystrophy, aging or other degenerative conditions, muscle loss can ...

MXene nanoparticle scaffolds have been shown to stimulate muscle growth, making them a promising option to treat muscle loss and damage. Now, researchers from Pusan National University explain the ...

Researchers in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions report a ...